The NRF2-KEAP1 pathway is an early responsive gene network in arsenic exposed lymphoblastoid cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Córdova, Emilio J ^a   Martínez Hernández, Angélica ^a   Uribe Figueroa, Laura ^a   Centeno, Federico ^a   Morales Marín, Mirna ^b   Koneru, Harsha ^c   Coleman, Matthew A ^c,d   Orozco, Lorena ^a,b  

^a INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARSENIC; B LYMPHOCYTE RECEPTOR; CHAPERONE; DNA; INTERFERON; KELCH LIKE ECH ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2; ARSENITE SODIUM; ARSENOUS ACID DERIVATIVE; KEAP1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; SIGNAL PEPTIDE; SODIUM DERIVATIVE;

ABCB6 GENE; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; DNA REPLICATION; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; GENE; GENE EXPRESSION; GENE TARGETING; HMOX1 GENE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MOLECULAR MECHANICS; SQSTM1 GENE; ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; DRUG EFFECTS; GENE REGULATORY NETWORK; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; ARSENITES; CELL LINE, TUMOR; GENE EXPRESSION; GENE REGULATORY NETWORKS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-E2-RELATED FACTOR 2; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SIGNAL TRANSDUCTION; SODIUM COMPOUNDS;

EID: 84895739598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088069     Document Type: Article

References (49)

1. Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ (2011) Arsenic Exposure and Toxicology: A Historical Perspective. Toxicol Sci 123: 305-32.
2. Rahman MM, Ng JC, Naidu R (2009) Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health 31: 189-200.
3. Bosnjak Z, Cavar S, Klapec T, Milic M, Klapec-Basar M, et al. (2008) Selected markers of cardiovascular disease in a population exposed to arsenic from drinking water. Environ Toxicol Pharmacol 26: 181-6.
4. Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, et al. (2009) Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect 117: 1718-23.
5. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E (2008) Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300: 814-22.
6. Morzadec C, Bouezzedine F, Macoch M, Fardel O, Vernhet L (2012) Inorganic arsenic impairs proliferation and cytokine expression in human primary T lymphocytes. Toxicology 300: 46-56.
7. Das S, Pan D, Bera AK, Rana T, Bhattacharya D, et al. (2011) Sodium arsenite mediated immuno-disruption through alteration of transcription profile of cytokines in chicken splenocytes under in vitro system. Mol Biol Rep 38: 171-6.
8. Biswas R, Poddar S, Mukherjee A (2007) Investigation on the genotoxic effects of long-term administration of sodium arsenite in bone marrow and testicular cells in vivo using the comet assay. J Environ Pathol Toxicol Oncol 26: 29-37. (Pubitemid 46986244)
9. Ding W, Hudson LG, Liu KJ (2005) Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol Cell Biochem 279: 05-12.
10. Noreault TL, Kostrubsky VE, Wood SG, Nichols RC, Strom SC, et al. (2005) Arsenite decreases CYP3A4 and RXRalpha in primary human hepatocytes. Drug Metab Dispos 33: 993-1003. (Pubitemid 41002782)
11. Smeester L, Rager JE, Bailey KA, Guan X, Smith N, et al. (2011) Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol 24: 165-7.
12. He X, Chen MG, Lin GX, MaQ (2006) Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 x Keap1 x Cul3 complex and recruiting Nrf2 x Maf to the antioxidant response element enhancer. J Biol Chem. 281: 23620-31. (Pubitemid 44274137)
13. McDonald JT, Kim K, Norris AJ, Vlashi E, Phillips TM, et al. (2010) Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res 70: 8886-95.
14. Shen G, Kong AN (2009) Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm Drug Dispos 30: 345-55.
15. Taguchi K, Motohashi H, Yamamoto M (2011) Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16: 123-40.
16. Aono J, Yanagawa T, Itoh K, Li B, Yoshida H, et al. (2003) Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. Biochem Biophys Res Commun. 30: 271-7. (Pubitemid 36555463)
17. Li B, Li X, Zhu B, Zhang X, Wang Y, et al. (2011) Sodium arsenite induced reactive oxygen species generation, nuclear factor (erythroid-2 related) factor 2 activation, heme oxygenase-1 expression, and glutathione elevation in Chang human hepatocytes. Environ Toxicol. Aug 1.
18. Pi J, Qu W, Reece JM, Kumagai Y, Waalkes MP (2003) Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp Cell Res. 290: 234-45. (Pubitemid 37272168)
19. Bailey KA, Hester SD, Knapp GW, Owen RD, Thai SF (2010) Gene expression of normal human epidermal keratinocytes modulated by trivalent arsenicals. Mol Carcinog. 49: 981-98.
20. Kawata K, Shimazaki R, Okabe S (2009) Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis. Environ Mol Mutagen. 1: 46-59.
21. Zheng XH, Watts GS, Vaught S, Gandolfi AJ (2003) Low-level arsenite induced gene expression in HEK293 cells. Toxicology. 187: 39-48. (Pubitemid 36388757)
22. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 29: 365-71. (Pubitemid 34326681)
23. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3, 1101-8. (Pubitemid 351818697)
24. Chien V, Aitken JF, Zhang S, Buchanan CM, Hickey A, et al. (2010) The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of beta-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes. Biochem J. 432: 13-21.
25. Ojha J, Masilamoni G, Dunlap D, Udoff RA, Cashikar AG (2011) Sequestration of Toxic Oligomers by HspB1 as a Cytoprotective Mechanism. Mol Cell Biol. 31: 3146-57.
26. Robichon C, Varret M, Le Liepvre X, Lasnier F, Hajduch, E, et al. 2006. DnaJA4 is a SREBP-regulated chaperone involved in the cholesterol biosynthesis pathway. Biochim Biophys Acta. 1761, 1107-13. (Pubitemid 44376735)
27. Andrew AS, Bernardo V, Warnke LA, Davey JC, Hampton T, et al. (2007) Exposure to arsenic at levels found in U.S. drinking water modifies expression in the mouse lung. Toxicol Sci 100: 75-87. (Pubitemid 47617805)
28. Andrew AS, Warren AJ, Barchowsky A, Temple KA, Klei L, et al. (2003) Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ Health Perspect. 111: 825-35.
29. Han SG, Castranova V, Vallyathan V (2005) Heat shock protein 70 as an indicator of early lung injury caused by exposure to arsenic. Mol Cell Biochem 277: 153-64. (Pubitemid 41236198)
30. Hernandez-Zavala A, Cordova E, Del Razo LM, Cebrian ME, Garrido E (2005) Effects of arsenite on cell cycle progression in a human bladder cancer cell line. Toxicology 207: 49-57. (Pubitemid 39601685)
31. Lehmann GM, McCabe MJ Jr (2007) Arsenite slows S phase progression via inhibition of cdc25A dual specificity phosphatase gene transcription. Toxicol Sci. 99: 70-8. (Pubitemid 47250368)
32. LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED (2005) HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19: 662-4. (Pubitemid 40471278)
33. Abiko Y, Shinkai Y, Sumi D, Kumagai Y (2010) Reduction of arsenic-induced cytotoxicity through Nrf2/HO-1 signaling in HepG2 cells. J Toxicol Sci. 35: 419-23.
34. Wang XJ, Sun Z, Chen W, Eblin KE, Gandolfi JA, et al. (2007) Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol Appl Pharmacol. 225: 206-13. (Pubitemid 350088062)
35. Andrew AS, Jewell DA, Whitfield ML, Moore JH, Karagas MR (2008) Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 116: 524-31. (Pubitemid 351864314)
36. Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, et al. (2006) Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol Biomarkers. 15: 1367-75. (Pubitemid 44125296)
37. Bolt AM, Douglas RM, Klimecki WT (2010) Arsenite exposure in human lymphoblastoid cell lines induces autophagy and coordinated induction of lysosomal genes. Toxicol Lett. 30: 153-9.
38. Fujiwara Y, Honda A, Satoh M (2010) DNA microarray gene expression analysis of human vascular endothelial cells exposed to arsenite. J Toxicol Sci 35: 275-8.
39. Martin-Chouly C, Morzadec C, Bonvalet M, Galibert MD, Fardel O, et al. (2011) Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Mol Immunol. 48: 956-65.
40. Su PF, Hu YJ, Ho IC, Cheng YM, Lee TC (2006) Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites. Environ Health Perspect. 114: 394-403.
41. Rea MA, Gregg JP, Qin Q, Phillips MA, Rice RH (2003) Global alteration of gene expression in human keratinocytes by inorganic arsenic. Carcinogenesis. 24: 747-56. (Pubitemid 36592410)
42. Matsumoto G, Wada K, Okuno M, Kurosawa M. Nukina N (2011) Serine 403 phosphorylation of p62/sqstm1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell. 44: 279-89.
43. Jain A, Lamark T, Sjøttem E, Larsen KB, Awuh JA, et al. (2010) p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem. 285: 22576-91.
44. Furuya KN, Bradley G, Sun D, Schuetz EG, Schuetz JD (1997) Identification of a new P-glycoprotein-like ATP-binding cassette transporter gene that is overexpressed during hepatocarcinogenesis. Cancer Res. 57: 3708-3716. (Pubitemid 27381213)
45. Krishnamurthy PC, Du G, Fukuda Y, Sun D, Sampath J, et al. (2006) Identification of a mammalian mitochondrial porphyrin transporter. Nature 443: 586-589. (Pubitemid 44527295)
46. Lynch J, Fukuda Y, Krishnamurthy P, Du G, Schuetz JD (2009) Cell survival under stress is enhanced by a mitochondrial ATP-binding cassette transporter that regulates hemoproteins. Cancer Res. 69: 5560-5567.
47. Chavan H, Oruganti M, Krishnamurthy P (2011) The ATP-binding cassette transporter ABCB6 is induced by arsenic and protects against arsenic cytotoxicity. Toxicol Sci. 120: 519-28.
48. Campbell MR, Karaca M, Adamski KN, Chorley BN, Wang X, et al. (2013) Novel hematopoietic target genes in the NRF2-mediated transcriptional pathway. Oxid Med Cell Longev 2013: 1203-15.
49. Yih LH, Peck K, Lee TC (2002) Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis 23: 867-76. (Pubitemid 34567528)